BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31092733)

  • 1. Polycomb repressive complex 2 is a critical mediator of allergic inflammation.
    Keenan CR; Iannarella N; Garnham AL; Brown AC; Kim RY; Horvat JC; Hansbro PM; Nutt SL; Allan RS
    JCI Insight; 2019 May; 4(10):. PubMed ID: 31092733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8
    Gray SM; Amezquita RA; Guan T; Kleinstein SH; Kaech SM
    Immunity; 2017 Apr; 46(4):596-608. PubMed ID: 28410989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polycomb repressive complex 2 governs life and death of peripheral T cells.
    Zhang Y; Kinkel S; Maksimovic J; Bandala-Sanchez E; Tanzer MC; Naselli G; Zhang JG; Zhan Y; Lew AM; Silke J; Oshlack A; Blewitt ME; Harrison LC
    Blood; 2014 Jul; 124(5):737-49. PubMed ID: 24951427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.
    Christofides A; Karantanos T; Bardhan K; Boussiotis VA
    Oncotarget; 2016 Dec; 7(51):85624-85640. PubMed ID: 27793053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezh2 loss propagates hypermethylation at T cell differentiation-regulating genes to promote leukemic transformation.
    Wang C; Oshima M; Sato D; Matsui H; Kubota S; Aoyama K; Nakajima-Takagi Y; Koide S; Matsubayashi J; Mochizuki-Kashio M; Nakano-Yokomizo T; Bai J; Nagao T; Kanai A; Iwama A; Sashida G
    J Clin Invest; 2018 Aug; 128(9):3872-3886. PubMed ID: 30080177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezh2 controls development of natural killer T cells, which cause spontaneous asthma-like pathology.
    Tumes D; Hirahara K; Papadopoulos M; Shinoda K; Onodera A; Kumagai J; Yip KH; Pant H; Kokubo K; Kiuchi M; Aoki A; Obata-Ninomiya K; Tokoyoda K; Endo Y; Kimura MY; Nakayama T
    J Allergy Clin Immunol; 2019 Aug; 144(2):549-560.e10. PubMed ID: 30851295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezh2 lines up the chromatin in T regulatory cells.
    Wu C; Chen Z; Kuchroo VK
    Immunity; 2015 Feb; 42(2):201-203. PubMed ID: 25692693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Polycomb group protein EZH2 directly controls DNA methylation.
    Viré E; Brenner C; Deplus R; Blanchon L; Fraga M; Didelot C; Morey L; Van Eynde A; Bernard D; Vanderwinden JM; Bollen M; Esteller M; Di Croce L; de Launoit Y; Fuks F
    Nature; 2006 Feb; 439(7078):871-4. PubMed ID: 16357870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Basis of the Interaction Between Ubiquitin Specific Protease 7 and Enhancer of Zeste Homolog 2.
    Gagarina V; Bojagora A; Lacdao IK; Luthra N; Pfoh R; Mohseni S; Chaharlangi D; Tan N; Saridakis V
    J Mol Biol; 2020 Feb; 432(4):897-912. PubMed ID: 31866294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.
    DuPage M; Chopra G; Quiros J; Rosenthal WL; Morar MM; Holohan D; Zhang R; Turka L; Marson A; Bluestone JA
    Immunity; 2015 Feb; 42(2):227-238. PubMed ID: 25680271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications.
    Li B; Chng WJ
    J Hematol Oncol; 2019 Nov; 12(1):118. PubMed ID: 31752930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.
    Wen Y; Cai J; Hou Y; Huang Z; Wang Z
    Oncotarget; 2017 Jun; 8(23):37974-37990. PubMed ID: 28415635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the EZH2 histone methyltransferase in cancer epigenetics.
    Simon JA; Lange CA
    Mutat Res; 2008 Dec; 647(1-2):21-9. PubMed ID: 18723033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-203 Interplays with Polycomb Repressive Complexes to Regulate the Proliferation of Neural Stem/Progenitor Cells.
    Liu PP; Tang GB; Xu YJ; Zeng YQ; Zhang SF; Du HZ; Teng ZQ; Liu CM
    Stem Cell Reports; 2017 Jul; 9(1):190-202. PubMed ID: 28602614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 as a mediator of treatment resistance in melanoma.
    Tiffen JC; Gallagher SJ; Tseng HY; Filipp FV; Fazekas de St. Groth B; Hersey P
    Pigment Cell Melanoma Res; 2016 Sep; 29(5):500-7. PubMed ID: 27063195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycomb Repressive Complex 2 Proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Genes With Euchromatic Promoters in Mice.
    Grindheim JM; Nicetto D; Donahue G; Zaret KS
    Gastroenterology; 2019 May; 156(6):1834-1848. PubMed ID: 30689973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.
    Aoki R; Chiba T; Miyagi S; Negishi M; Konuma T; Taniguchi H; Ogawa M; Yokosuka O; Iwama A
    J Hepatol; 2010 Jun; 52(6):854-63. PubMed ID: 20395008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
    Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
    Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs.
    Shan Y; Liang Z; Xing Q; Zhang T; Wang B; Tian S; Huang W; Zhang Y; Yao J; Zhu Y; Huang K; Liu Y; Wang X; Chen Q; Zhang J; Shang B; Li S; Shi X; Liao B; Zhang C; Lai K; Zhong X; Shu X; Wang J; Yao H; Chen J; Pei D; Pan G
    Nat Commun; 2017 Sep; 8(1):672. PubMed ID: 28939884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells.
    Koppens MA; Bounova G; Gargiulo G; Tanger E; Janssen H; Cornelissen-Steijger P; Blom M; Song JY; Wessels LF; van Lohuizen M
    Gastroenterology; 2016 Oct; 151(4):684-697.e12. PubMed ID: 27342214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.